Chief Executive Officer and founder
Fox Chase Therapeutics Discovery Inc.
Doylestown, Pennsylvania, United States
Disclosure information not submitted.
Poster K5 - Cell-Type Specific Effects of Tetrahydrocannabinol on Epileptogenesis
Thursday, October 24, 2024
2:45 PM - 3:45 PM EST